IHC staining found that 62% of cases positively expressed SOX13 protein with weak or moderate cytoplasmic/nuclear staining in pancreatic cancer lesions (Figures 5(a)–5(d)). This evidence concerns the gene SOX13 and pancreatic neoplasm.